Overview

The Optimal Radioimmunotherapy Combinations for Advanced TNBC

Status:
RECRUITING
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This study aims to explore the best combination patterns of radiotherapy and immunotherapy for advanced triple-negative breast cancer (TNBC).
Phase:
PHASE2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
First Affiliated Hospital Xi'an Jiaotong University
West China Hospital
Treatments:
toripalimab